Approximately 90% of rare diseases still have no effective treatments, despite regulators implementing expedited approval pathways for these indications.
Read More
Approximately 90% of rare diseases still have no effective treatments, despite regulators implementing expedited approval pathways for these indications.
Read More
Health Rss 